Photodynamic therapy of primary skin cancer: A review

Dougherty, 1993, Photodynamic therapy: yearly review, Photochem Photobiol, 58, 895, 10.1111/j.1751-1097.1993.tb04990.x

Pass, 1993, Photodynamic therapy in oncology: mechanisms and clinical use, J Natl Cancer Inst, 85, 443, 10.1093/jnci/85.6.443

Daniell, 1991, A history of photodynamic therapy, Aust NZ J Surg, 61, 340, 10.1111/j.1445-2197.1991.tb00230.x

Raab, 1900, Ueber die Wirkung fluoreszierenden Stoffe auf Infusorien, Z Biol, 39, 524

von Tappeiner, 1903, Therapeutische Versuche mit fluoreszierenden Stoffen, Muenchener Medizinische Wochenschrift, 47, 2042

Jesionek, 1905, Zur Behandlung der Hautcarcinome mit fluoreszierenden Stoffen, Arch Klin Med, 82, 223

Kelly, 1975, Photodynamic destruction of human bladder carcinoma, Br J Cancer, 31, 237, 10.1038/bjc.1975.30

Dougherty, 1977, Phototherapy of human tumors, 435

Dougherty, 1979, Photoradiation in the treatment of recurrent breast carcinoma, J Natl Cancer Inst, 62, 231

Dougherty, 1987, Photosensitizers: therapy and detection of malignant tumors, Photochem Photobiol, 45, 874, 10.1111/j.1751-1097.1987.tb07898.x

Hilf, 1986, Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization of R3230A mammary tumors, Cancer Res, 46, 211

Gibson, 1988, Photosensitizing effects of hematoporphyrin derivative and Photofrin II on plasma membrane enzymes and 5′-nucleotidase, Na+ K+-ATPase and Mg2+-ATPase in RC3230AC mammary adenocarcinomas, Cancer Res, 48, 3360

Roberts, 1989, In vitro photosensitization II. An electron microscopy study of cellular destruction with mono-L-aspartyl chlorin e6 and Photofrin II, Lasers Surg Med, 9, 102, 10.1002/lsm.1900090204

Specht, 1990, Depolarization of mouse myeloma cell membranes during photodynamic action, Photochem Photobiol, 51, 319, 10.1111/j.1751-1097.1990.tb01717.x

Selman, 1984, Blood flow in transplantable bladder tumors treated with haematoporphyrin derivative and light, Cancer Res, 44, 1924

Stern, 1990, Photodynamic therapy with chloroaluminium sulfonated phthalocyanine in the rat window chamber, Am J Surg, 160, 360, 10.1016/S0002-9610(05)80543-4

Roberts, 1994, Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid, Int J Oncol, 5, 763

Henderson, 1992, How does photodynamic therapy work?, Photochem Photobiol, 55, 145, 10.1111/j.1751-1097.1992.tb04222.x

Jirsa, 1991, Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice, Eur J Cancer, 27, 109, 10.1016/0277-5379(91)90075-O

Roberts, 1995, Modulation of the response of a rodent fibrosarcoma to photodynamic therapy by hyperbaric oxygen treatment, Oncol Reports, 2, 387

Kessel, 1987, Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse phase chromatography, Photochem Photobiol, 46, 1023, 10.1111/j.1751-1097.1987.tb04888.x

Dougherty, 1987, Studies on the structure of porphyrins contained in PhotofrinR-II, Photochem Photobiol, 46, 569, 10.1111/j.1751-1097.1987.tb04815.x

Kessel, 1989, Chemistry of photosensitizing products derived from hematoporphyrin, 23

Lipson, 1961, The use of a derivative of hematoporphyrin in tumor detection, J Natl Cancer Inst, 26, 1

Lipson, 1964, A further evaluation of the use of hematoporphyrin derivative as a new aid for the endoscopic detection of malignant disease, Dis Chest, 46, 676, 10.1378/chest.46.6.676

Gregorie, 1968, Hematoporphyrin derivative fluorescenċe in malignant neoplasms, Ann Surg, 167, 820, 10.1097/00000658-196806000-00002

Doiron, 1979, Fluorescence bronchoscopy for detection of lung cancer, Chest, 76, 27, 10.1378/chest.76.1.27

Gomer, 1979, Determination of 3H and 14C hematoporphyrin derivative distribution in normal and malignant tissue, Cancer Res, 39, 146

Bugelski, 1981, Autoradiographic distribution of hematoporphyrin derivative in normal and tumour tissue of the mouse, Cancer Res, 41, 4606

Mang, 1987, Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics, Photochem Photobiol, 46, 853, 10.1111/j.1751-1097.1987.tb04859.x

Chan, 1988, Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminium sulfonated phthalocyanine in mice bearing transplantable tumours, Cancer Res, 48, 3040

Bown, 1993, Photodynamic therapy in gastroenterology — current status and future prospects, Endoscopy, 25, 683, 10.1055/s-2007-1010433

Svaasand, 1984, Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumours, 91

Wilson, 1985, In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues, Photochem Photobiol, 42, 153, 10.1111/j.1751-1097.1985.tb01554.x

Razum, 1987, Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivatives, HpD and DHE, Photochem Photobiol, 46, 925, 10.1111/j.1751-1097.1987.tb04870.x

Wooten, 1988, Prospective study of cutaneous photosensitivity after systemic hematoporphyrin derivative, Lasers Surg Med, 8, 294, 10.1002/lsm.1900080312

Roberts, 1989, Skin photosensitivity and photodestruction of several potential photodynamic sensitizers, Photochem Photobiol, 49, 431, 10.1111/j.1751-1097.1989.tb09191.x

Tralau, 1989, Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (AISPc): a comparative study, Photochem Photobiol, 49, 305, 10.1111/j.1751-1097.1989.tb04111.x

Levy, 1994, The preclinical and clinical development and potential application of benzoporphyrin derivative, International Photodynamics, 1, 3

Ris, 1991, Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results, Br J Cancer, 64, 1116, 10.1038/bjc.1991.474

Volz, 1992, Cutaneous phototoxicity of NPe6 in man, 421

Feather, 1990, Light delivery to tumour tissue through implanted optical fibres during photodynamic therapy, Lasers Med Sci, 5, 345, 10.1007/BF02032590

Whitehurst, 1995, Performance of a nonlaser light source for photodynamic therapy, 2371, 482

Dougherty, 1981, Photoradiation therapy for cutaneous and subcutaneous malignancies, J Invest Dermatol, 77, 122, 10.1111/1523-1747.ep12479341

Tse, 1984, Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome, Arch Ophthalmol, 102, 990, 10.1001/archopht.1984.01040030792018

Gregory, 1986, Application of photodynamic therapy in plastic surgery, Lasers Surg Med, 6, 62, 10.1002/lsm.1900060113

Waldow, 1987, Photodynamic therapy for treatment of malignant cutaneous lesions, Lasers Surg Med, 7, 451, 10.1002/lsm.1900070602

Pennington, 1988, Photodynamic therapy for multiple skin cancers, Plast Reconstr Surg, 82, 1067, 10.1097/00006534-198812000-00021

Robinson, 1988, Photodynamic therapy: a better treatment for widespread Bowen's disease, Br J Dermatol, 119, 59, 10.1111/j.1365-2133.1988.tb07101.x

Keller, 1989, Photodynamic therapy for nonmelanoma skin cancer, Facial Plast Surg, 6, 180, 10.1055/s-2008-1064728

Petrelli, 1992, Photodynamic therapy in the management of neoplasms of the perianal skin, Arch Surg, 127, 1436, 10.1001/archsurg.1992.01420120070013

Wilson, 1989, Use of photodynamic therapy for the treatment of extensive basal cell carcinomas, Facial Plast Surg, 6, 185, 10.1055/s-2008-1064729

Buscaglia, 1994, Photodynamic therapy with Photofrin successfully treats basal-cell carcinomas in patients with basal-cell nevus syndrome

Rowe, 1989, Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up, J Dermatol Surg Oncol, 15, 315, 10.1111/j.1524-4725.1989.tb03166.x

Wolf, 1993, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid, J Am Acad Dermatol, 28, 17, 10.1016/0190-9622(93)70002-B

Cairnduff, 1994, Superficial photodynamic therapy with topical 5-amino-laevulinic acid for superficial primary and secondary skin cancer, Br J Cancer, 69, 605, 10.1038/bjc.1994.112

Svanberg, 1994, Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation, Br J Dermatol, 130, 743, 10.1111/j.1365-2133.1994.tb03412.x

Warloe, 1994, Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma

Roberts, 1995, Distribution of protoporphyrin IX in Bowen's disease and basal cell carcinomas treated with topical 5-aminolaevulinic acid, 2371, 490